Stockholders' Equity (Tables)

6 Months Ended

Jun. 30, 2023

Stockholder's Equity [Abstract]

Schedule of company’s warrant activity

The following is a summary of the Company’s warrant activity for the six months ended June 30, 2023 (unaudited):

			Weighted		Weighted
			Average		Average
	Number of		Exercise		Remaining
	Shares		Price		Life
Outstanding at December 31, 2022		153,683	$	36.96	2.96 Years
Granted		344,212	$	3.39	4.87 Years
Exercised/cancelled		-
		497,895	$	13.75	4.13 Years

Schedule of grant date fair value of options granted

The Company determined the grant date fair value of options granted for the six months ended June 30, 2023, using the Black Scholes Method with the following assumptions:

Expected volatility	120.32%-124.08%
Expected term	5 years
Risk free rate	3.52% - 3.97%
Dividend rate	0.00%

Schedule of activity related to stock options

Activity related to stock options for the six months ended June 30, 2023 (unaudited), is summarized as follows:

				Weighted		Weighted
				Average		Average		Aggregate
	Number of			Exercise		Contractual		Intrinsic
	Shares			Price		Term (Yrs.)		Value
Outstanding at December 31, 2022		1,291,595		$	46.48		6.5	$	-
Granted		630,625		$	4.19		10.0	$	1,847,765
Exercised		-		$	-		-	$	-
Forfeited/cancelled		(361,150	)	$	52.86		-	$	-
Outstanding as of June 30, 2023		1,561,070		$	28.19		6.7	$	1,881,165
Exercisable as of June 30, 2023		810,268		$	40.28		4.4	$	40,899

Schedule of stock option

The following table summarizes stock option information as of June 30, 2023 (unaudited):

			Weighted
			Average
			Contractual
Exercise Price	Outstanding		Term (Yrs.)		Exercisable
Less than or equal $32.00		1,155,716		7.4		515,052
$32.01 - $56.00		17,917		3.0		17,917
$56.01 - $80.00		222,792		6.3		131,820
$80.01 - $128.00		164,645		3.4		145,479
		1,561,070		6.7		810,268